Concepedia

Tai Hato

TH

20

Publications

2.1K

Citations

18

H-Index

2008

Active since

Affiliations

Massachusetts General Hospital(Current)

Tokyo Metropolitan Komagome Hospital

Keio University

Harvard University

Teikyo University

Tai Hato is an author at Massachusetts General Hospital specializing in medicine, lung cancer, and radiation oncology.

ORCID

Top concepts

Publications per year

2008–2021

20

Publications

20

CXCR4 inhibition in tumor microenvironment facilitates anti‐programmed death receptor‐1 immunotherapy in sorafenib‐treated hepatocellular carcinoma in mice

Yunching Chen, Rakesh R. Ramjiawan, Thomas Reiberger et al. · Hepatology · 2014 · 444 citations

Dual Programmed Death Receptor‐1 and Vascular Endothelial Growth Factor Receptor‐2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma

Kohei Shigeta, Meenal Datta, Tai Hato et al. · Hepatology · 2019 · 398 citations · Full text

Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma

Kohei Shigeta, Aya Matsui, Hiroto Kikuchi et al. · Journal for ImmunoTherapy of Cancer · 2020 · 143 citations · Full text

Tumor Cell–Derived Angiopoietin-like Protein ANGPTL2 Is a Critical Driver of Metastasis

Motoyoshi Endo, Masahiro Nakano, Tsuyoshi Kadomatsu et al. · Cancer Research · 2012 · 141 citations

, , +14

Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages

João Incio, Priya Suboj, Shan M. Chin et al. · PLoS ONE · 2015 · 139 citations · Full text

Rows per page

1–5 of 20